Goa Pharma Summit 2026
India Pharma Rising
Competing in a New Global Order
September 30, 2026
Novotel Goa Panjim
Hall: Tiatr Lower Level
The Chancery Pavilion, Bengaluru
REGISTRATION: 9:00 AM to 10:00 AM
CONFERENCE & NETWORKING: 10:00 AM to 6:00 PM
Register Now Know more
PHARMA SUMMITS
The global pharma industry is going through a reset. Healthcare priorities are shifting, supply chains are being reconsidered, and expectations around quality, reliability and innovation are higher than ever before. Around the world, countries are looking for partners they can trust. Not just during crises, but for the long term.
India Pharma has earned that trust over decades. But today, the industry stands at a new crossroads.
The next phase is not only about supplying medicines at scale. It is about competing through innovation, strengthening global credibility, and building resilient systems that can support future healthcare needs.
Thought
Leadership
Innovation
Showcase
Global
Persepective
Networking
Opportunities
Key Topics
PPILT meets the patent cliff: Can Goa's pricing model handle a biologics wave?
• Has PPILT improved access to innovative therapies after one year?
• Can the model balance affordability, access and innovation?
• What does the patent cliff mean for biosimilars and high-value therapies?
• Can Goa become a testbed for innovative pricing models?
• Is the model scalable beyond Goa?
Beyond America: Finding India's next export growth engines
• How quickly can India reduce its US market dependence?
• Which markets offer the strongest next growth opportunities?
• Can complex generics, biosimilars and specialty products open new markets?
• What are the biggest barriers to diversification?
• Is diversification a strategy or simply a hedge?
From Panjim to the world: Goa's export playbook
• What has made Goa’s pharma export model successful?
• Can Goa move from manufacturing to higher-value exports?
• Where do CDMO, biologics and complex products fit?
• What infrastructure and policy changes are needed?
• Can Goa become a preferred global pharma export base?
ADVANTAGE GOA
A pharma heavyweight
100+ manufacturing units, with Pfizer, Cipla, Glenmark, Lupin, Encube Ethicals, Abbott and Sanofi among companies present in the state.
An innovation runway
Growing R&D capabilities could open opportunities in biologics, genomics and personalised medicine.
Export-led by pharma
Pharmaceuticals account for nearly 48 percent of Goa's merchandise exports, giving the state a strong global-market orientation.
Built for global markets
West-coast location, port access, export infrastructure and international-standard manufacturing strengthen Goa's global proposition.
From plants to partnerships
An established manufacturing base creates room for R&D, CDMO/CRDMO and higher-value pharma activities.
Talent to scale
A skilled workforce supports pharma manufacturing, research, quality and management.
The next investment wave
Expanding manufacturing capacities point to continued opportunities for fresh pharma investment.
Policy backing
Drugs & Pharmaceuticals is a priority sector, with government support for investment, infrastructure and employment.

Express Pharma, first published as Express Pharma Pulse in 1994, is today India’s leading business fortnightly for the pharmaceutical industry. With the patronage of its readers, Express Pharma has grown to become the No.1 Business News Magazine for the pharmaceutical industry. The editorial contents include: news, views, analysis and interviews, under four main segments: Market (The business of pharmaceuticals), Management (Insight for managing pharma), Research (Expertise for drug development) and Pharma Life (HR issues with a pharma focus). Besides this, we bring out periodic specials like the quarterly Pharma Technology Review, Packaging Special and LABNEXT.

Follow us

Quick Links

Our Network

Express Pharma

Copyright © The Indian Express [P] Ltd. All Rights Reserved.